Canada Markets open in 8 hrs 1 min

Canntab Therapeutics Limited (PILL.CN)

Canadian Sec - Canadian Sec Delayed Price. Currency in CAD
Add to watchlist
0.7000+0.0400 (+6.06%)
At close: 2:41PM EDT
Full screen
Previous Close0.6600
Bid0.7000 x 0
Ask0.7400 x 0
Day's Range0.0000 - 0.0000
52 Week Range
Avg. Volume34,910
Market Cap22.027M
Beta (5Y Monthly)1.55
PE Ratio (TTM)N/A
EPS (TTM)-0.0860
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateMar. 08, 2016
1y Target EstN/A
  • CNW Group

    IIROC Trade Resumption - PILL

    VANCOUVER, BC , June 2, 2020 /CNW/ - Trading resumes in: Company:  Canntab Therapeutics Limited CSE Symbol: PILL (all issues) Resumption (ET): 11:45 AM IIROC can make a decision to impose a temporary suspension ...

  • Canntab and Medipharm Labs Enter Into a Wholesale Tablet Purchase Agreement
    CNW Group

    Canntab and Medipharm Labs Enter Into a Wholesale Tablet Purchase Agreement

    TORONTO, June 2, 2020 /CNW/ - Canntab Therapeutics Limited (CSE:PILL.CN - News)(OTCQB:CTABF - News) (FRA:TBF1.F - News) (the "Company" or "Canntab"), the leading innovator in cannabinoid and terpene blends in hard pill form for therapeutic applications, is pleased to announce that it is today beginning production of its instant release tablets and has already entered into its first purchase agreement with MediPharm Labs ("MediPharm") (TSX:LABS.TO - News)(OTCQX:MEDIF - News)(Deutsche Borse: MLZ), a global leader in pharma quality cannabinoid based products. Orders under the agreement will be composed of a mix of Canntab's proprietary instant release tablets delivering THC, CBD and a combination of THC/CBD in 12 different strengths. MediPharm will purchase and distribute cannabis products on a non-exclusive basis across Canada, through licensed provincial dispensaries.

  • CNW Group

    IIROC Trading Halt - PILL

    IIROC Trading Halt - PILL